DiscoverNeuro Current: An SfN Journals Podcast#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies
#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

Update: 2025-01-21
Share

Description

Karl Herrup, Michelle Jin, and James Noble share their perspectives on evaluating the clinical impacts of emerging treatments for Alzheimer’s Disease with eNeuro Editor-in-Chief Christophe Bernard. Find our upcoming webinar schedule here.

With special guests:

Karl Herrup, Michelle Jin, and James Noble

Hosted by:

Christophe Bernard

On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeuroscieNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system. 

Find out more about SfN and connect with us on XInstagram, and LinkedIn.  

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

Society for Neuroscience